Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions

Details for Australian Patent Application No. 2006259897 (hide)

Owner AstraZeneca AB

Inventors Starke, Ingemar; Alenfalk, Susanne; Hunegnaw, Fana; Karlsson, Staffan; Dahlstrom, Mikael; Lemurell, Malin

Agent Davies Collison Cave

Pub. Number AU-B-2006259897

PCT Pub. Number WO2006/137796

Priority 0501465-9 22.06.05 SE

Filing date 21 June 2006

Wipo publication date 28 December 2006

Acceptance publication date 2 September 2010

International Classifications

C07D 205/08 (2006.01) Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/137796 Priority application(s): WO2006/137796

2 September 2010 Application Accepted

  Published as AU-B-2006259897

6 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006259898-Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions

2006259895-New2-azetidinone derivatives for the treatment of hyperlipidaemic diseases